Exchange:
Industry: Pharmaceuticals & Biotechnology
Last Trade: 4:00 PM ET 4/5/2013
Last 10 Quotes:
What's This?
| Most Recent Quarter ($) | Same Quarter Last Year ($) | % Change | |
| EPS, Pro Forma | 0.56 | 0.29 | 96.69 |
| EPS, GAAP | 0.53 | 0.08 | 0.08 |
| Consensus Estimate | 0.41 | 0.34 | 20.59 |
| Trailing 12 Months | Year-Earlier Period | % Change | |
| EPS, Pro Forma | 1.32 | 0.88 | 49.60 |
| EPS, GAAP | 1.13 | 0.62 | 81.45 |
| Consensus Estimate | 1.58 | 1.29 | 22.44 |
| ILMN | Industry Average | |
| P/E (TTM) | 44.61 | NA |
| P/E (Forward) | 34.33 | NA |
| PEG Ratio | 1.94 | 2.19 |
| Price/Sales | 5.88 | 18.50 |
| Beta | 0.85 | 0.70 |
| 4/3/2013 | New Questions on Cutting-Edge Prenatal Tests (WSJ.com) |
| 3/6/2013 | Private Equity Group Reportedly Looking At Life Technologies (Barrons.com) |
| 3/1/2013 | Top Analyst Upgrades and Downgrades (AL, ALU, AIG, AFL, BUD, ADSK, DRI, DB, DUK, HA, ILMN, IP, ISRG, NWL, NCLH, CRM, SQNM, TEF, V) (24/7 Wall St) |
| 1/10/2013 | Barron's Online Report Card (Barrons.com) |
| 1/7/2013 | Illumina's Darkening Outlook (Barrons.com) |
| 1/7/2013 | Biotech and BioHealth Top Stocks on the Move (ACHN, CBMX, DNDN, EXAS, ILMN, PPHM, VVUS) (24/7 Wall St) |
